These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2560079)

  • 1. [Significance of prolyl hydroxylase analysis in clinical tests].
    Yamada S; Kawasaki H
    Nihon Rinsho; 1989 Dec; 48 Suppl():321-3. PubMed ID: 2560079
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
    Murawaki Y; Kusakabe Y; Hirayama C
    Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of serum prolyl hydroxylase in diabetic microangiopathy].
    Shioi A; Nishizawa Y; Morii H
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():126-8. PubMed ID: 9513402
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of serum prolyl hydroxylase analysis in the diagnosis of diabetic diseases].
    Shioi A; Nishizawa Y; Morii H
    Nihon Rinsho; 1990 Dec; 48 Suppl():370-3. PubMed ID: 1964975
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver immunoreactive prolyl hydroxylase protein in human primary hepatocellular carcinoma.
    Bolarin D; Andy JJ; Alabi ZO
    Hepatogastroenterology; 1983 Dec; 30(6):230-2. PubMed ID: 6327476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of alpha-fetoprotein assay as a tumor marker].
    Endo Y; Iino S; Miyazaki J
    Nihon Rinsho; 1990 Feb; 48 Suppl():949-52. PubMed ID: 1693988
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of serum prolyl hydroxylase beta-subunit levels determined using monoclonal antibody].
    Yasuhara M; Matsuda Y; Takada A
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jun; 84(6):1225-32. PubMed ID: 2822982
    [No Abstract]   [Full Text] [Related]  

  • 8. Protocollagen proline hydroxylase in sera of Ugandans with hepatocellular carcinoma.
    Keiser HR; Vogel CL; Sadikali F
    J Natl Cancer Inst; 1972 Nov; 49(5):1251-5. PubMed ID: 4119495
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of the determination of serum immunoreactive prolyl hydroxylase (SIRPH) in hepatic fibrosis].
    Suzuki H; Suzuki M; Okabe K; Uchikoshi T
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jun; 84(6):1265-71. PubMed ID: 2822984
    [No Abstract]   [Full Text] [Related]  

  • 10. Is serum prolyl 4-hydroxylase useful as noninvasive marker of liver fibrosis in patients with biliary atresia?
    Kobayashi H; Tamura T; Yamataka A; Lane GJ; Miyano T
    J Pediatr Surg; 2005 Aug; 40(8):1366-7. PubMed ID: 16080952
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of serum ferritin determination for hepatocellular carcinoma.
    Nakano S; Kumada T; Sugiyama K; Watahiki H; Takeda I
    Am J Gastroenterol; 1984 Aug; 79(8):623-7. PubMed ID: 6205585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary carcinoma of the liver.
    Chan CH
    Med Clin North Am; 1975 Jul; 59(4):989-94. PubMed ID: 49467
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatic fibrosis and its serum markers].
    Okabe K
    Rinsho Byori; 1992 Dec; 40(12):1258-64. PubMed ID: 1339165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum and tissue prolyl hydroxylase (PH) in hepatocellular carcinoma and gastrointestinal cancer].
    Suzuki M; Suzuki H; Kato Y; Okabe K; Uchikoshi T; Okazaki N
    Nihon Shokakibyo Gakkai Zasshi; 1988 Oct; 85(10):2232-8. PubMed ID: 2850377
    [No Abstract]   [Full Text] [Related]  

  • 15. Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease. I. Prolyl hydroxylase.
    Kuutti-Savolainen ER; Risteli J; Miettinen TA; Kivirikko KI
    Eur J Clin Invest; 1979 Feb; 9(1):89-95. PubMed ID: 222594
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatocellular carcinomas do not compromise quantitative tests of liver function.
    Ganslmayer M; Ocker M; Zopf S; Schuppan D; Hahn EG; Herold C
    Hepatogastroenterology; 2005; 52(63):881-4. PubMed ID: 15966225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course of chronic hepatitis C in patients with very high serum alpha-fetoprotein levels and normal hepatic imaging.
    Gonzalez SA; Jacobson IM
    Am J Gastroenterol; 2005 Apr; 100(4):977-8. PubMed ID: 15784045
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum prolyl hydroxylase protein in experimental liver cancer.
    Bolarin DM
    Acta Physiol Hung; 1988; 71(1):55-9. PubMed ID: 2839006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Punch biopsies of the liver. Phase-contrast microscopic examination].
    Lamotte M; Martin E; Segrestaa JM; Caulin C
    Presse Med (1893); 1967 Jun; 75(30):1557-62. PubMed ID: 4290845
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolylhydroxylase and procollagen type III in long-term survivors of acute lymphoblastic leukemia (ALL): a biochemical approach to HCV-related liver disease.
    Leonardi S; La Spina M; La Rosa M; Schilirò G
    Med Pediatr Oncol; 2003 Jul; 41(1):17-20. PubMed ID: 12764737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.